why Solid Biosciences Inc [SLDB] is a Good Choice for Investors After New Price Target of $16.70

Solid Biosciences Inc [NASDAQ: SLDB] stock went on a downward path that fall over -20.33% on Tuesday, amounting to a one-week price increase of more than 10.49%.

Over the last 12 months, SLDB stock dropped by -67.06%. The one-year Solid Biosciences Inc stock forecast points to a potential upside of 79.82. The average equity rating for SLDB stock is currently 1.08, trading closer to a bullish pattern in the stock market.

The market cap for the stock reached $261.18 million, with 77.50 million shares outstanding and 64.41 million shares in the current float. Compared to the average trading volume of 2.73M shares, SLDB stock reached a trading volume of 3276382 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on Solid Biosciences Inc [SLDB]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SLDB shares is $16.70 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SLDB stock is a recommendation set at 1.08. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Truist have made an estimate for Solid Biosciences Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 08, 2025. While these analysts kept the previous recommendation, Wedbush raised their target price to Outperform. The new note on the price target was released on December 13, 2024, representing the official price target for Solid Biosciences Inc stock. Previously, the target price had yet another raise to $15, while JMP Securities analysts kept a Mkt Outperform rating on SLDB stock. On July 15, 2024, analysts increased their price target for SLDB shares from 10 to 15.

The Average True Range (ATR) for Solid Biosciences Inc is set at 0.43 The Price to Book ratio for the last quarter was 0.99, with the Price to Cash per share for the same quarter was set at 1.92.

SLDB Stock Performance Analysis:

Solid Biosciences Inc [SLDB] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 10.49. With this latest performance, SLDB shares gained by 8.19% in over the last four-week period, additionally sinking by -38.95% over the last 6 months – not to mention a drop of -67.06% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SLDB stock in for the last two-week period is set at 47.46, with the RSI for the last a single of trading hit 47.56, and the three-weeks RSI is set at 46.92 for Solid Biosciences Inc [SLDB]. The present Moving Average for the last 50 days of trading for this stock 4.11, while it was recorded at 3.77 for the last single week of trading, and 5.56 for the last 200 days.

Insight into Solid Biosciences Inc Fundamentals:

Solid Biosciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.20 and a Current Ratio set at 5.20.

SLDB Stock EPS

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SLDB. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Solid Biosciences Inc go to 18.18%.

Solid Biosciences Inc [SLDB] Institutonal Ownership Details

The top three institutional holders of SLDB stocks are: PERCEPTIVE ADVISORS LLC with ownership of 6.91 million shares, which is approximately 16.8725%. RA CAPITAL MANAGEMENT, L.P., holding 4.33 million shares of the stock with an approximate value of $$24.55 million in SLDB stocks shares; and RA CAPITAL MANAGEMENT, L.P., currently with $$22.88 million in SLDB stock with ownership which is approximately 9.8562%.

The DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.